Metformin ameliorates ROS-p53-collagen axis of fibrosis and dyslipidemia in type 2 diabetes mellitus-induced left ventricular injury

References

• Aragno, M., et al., 2008. Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology, 149 (1), 380–388.
   PubMed Web of Science ®Google Scholar
• Barazzoni, R., et al., 2012. Adipokines, ghrelin and obesity-associated insulin resistance in nondiabetic patients with acute coronary syndrome. Obesity, 20 (12), 2348–2353.
   PubMed Web of Science ®Google Scholar
• Bhandary, Y.P., et al., 2013. Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1. The American journal of pathology, 183 (1), 131–143.
   PubMed Web of Science ®Google Scholar
• Chen, Y., et al., 2018. The tango of ROS and p53 in tissue stem cells. Cell death and differentiation, 25 (4), 639–641.
   PubMed Web of Science ®Google Scholar
• Collino, M., et al., 2010. Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation. British journal of pharmacology, 160 (8), 1892–1902.
   PubMed Web of Science ®Google Scholar
• Dallak, M., et al., 2020. Suppression of glomerular damage and apoptosis and biomarkers of acute kidney injury induced by acetaminophen toxicity using a combination of resveratrol and quercetin. Drug and chemical toxicology, 1–7.
   Google Scholar
• Danaei, G., et al., 2011. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet (London, England), 378 (9785), 31–40.
   PubMed Web of Science ®Google Scholar
• Eckel, R.H., Grundy, S.M., and Zimmet, P.Z., 2005. The metabolic syndrome. Lancet (London, England), 365 (9468), 1415–1428.
   PubMed Web of Science ®Google Scholar
• Ference, B.A., et al., 2017. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European heart journal, 38 (32), 2459–2472.
   PubMed Web of Science ®Google Scholar
• Fujii, H., et al., 2010. Oxidative and nitrosative stress and progression of diabetic nephropathy in type 2 diabetes. American journal of nephrology, 31 (4), 342–352.
   PubMed Web of Science ®Google Scholar
• Gogiraju, R., et al., 2015. Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice. Journal of the American heart association, 4(2), 132–140.
   Web of Science ®Google Scholar
• Grattagliano, I., et al., 2008. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. Journal of nutritional biochemistry, 19 (8), 491–504.
   PubMed Web of Science ®Google Scholar
• Higgins, S.P., et al., 2018. TGF-β1/p53 signaling in renal fibrogenesis. Cellular signalling, 43, 1–10.
   PubMed Web of Science ®Google Scholar
• Kai, H., et al., 2006. Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II. Hypertension research: official journal of the Japanese society of hypertension, 29 (9), 711–718.
   PubMed Web of Science ®Google Scholar
• Kayama, Y., et al., 2015. Diabetic cardiovascular disease induced by oxidative stress. International journal of molecular sciences, 16 (10), 25234–25263.
   PubMed Web of Science ®Google Scholar
• Kim, J., et al., 2009. Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice. American journal of physiology. renal physiology, 297 (2), F461–F470.
   PubMed Web of Science ®Google Scholar
• Kodama, T., et al., 2011. Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice. The journal of clinical investigation, 121 (8), 3343–3356.
   PubMed Web of Science ®Google Scholar
• Kopelman, P.G., 2000. Obesity as a medical problem. Nature, 404 (6778), 635–643.
   PubMed Web of Science ®Google Scholar
• Laakso, M., 2010. Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes care, 33 (2), 442–449.
   PubMed Web of Science ®Google Scholar
• Li, C.J., et al., 2012. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Cardiovascular diabetology, 11, 73.
   PubMed Web of Science ®Google Scholar
• Low wang, C.C., et al., 2016. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations. Circulation, 133 (24), 2459–2502.
   PubMed Web of Science ®Google Scholar
• Luangmonkong, T., et al., 2018. Targeting oxidative stress for the treatment of liver fibrosis. Reviews of physiology, biochemistry and pharmacology, 175, 71–102.
   PubMed Web of Science ®Google Scholar
• Otsuka, T., et al., 2016. Dyslipidemia and the risk of developing hypertension in a working-age male population. Journal of the American heart association, 5, e003053.
   PubMed Web of Science ®Google Scholar
• Rafieian-kopaei, M., et al., 2014. Atherosclerosis: process, indicators, risk factors and new hopes. International journal of preventive medicine, 5 (8), 927–946.
   PubMedGoogle Scholar
• Ronti, T., Lupattelli, G., and Mannarino, E., 2006. The endocrine function of adipose tissue: an update. Clinical endocrinology, 64 (4), 355–365.
   PubMed Web of Science ®Google Scholar
• Sarwar, N., et al., 2010. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (London, England), 375 (9733), 2215–2222.
   PubMed Web of Science ®Google Scholar
• Van bilsen, M., et al., 2014. Hypertension is a conditional factor for the development of cardiac hypertrophy in type 2 diabetic mice. PLoS One, 9 (1), e85078.
   PubMed Web of Science ®Google Scholar
• Vargas-robles, H., et al., 2015. Antioxidative diet supplementation reverses high-fat diet-induced increases of cardiovascular risk factors in mice. Oxidative medicine and cellular longevity, 467471, 1.
   Google Scholar
• Welty, F.K., 2001. Cardiovascular disease and dyslipidemia in women. Archives of internal medicine, 161 (4), 514–522.
   PubMedGoogle Scholar
• Yaghi, S., and Elkind, M.S., 2015. Lipids and cerebrovascular disease: research and practice. Stroke, 46 (11), 3322–3328.
   PubMed Web of Science ®Google Scholar